安徽医科大学学报
安徽醫科大學學報
안휘의과대학학보
ACTA UNIVERSITY MEDICINALIS ANHUI
2015年
4期
481-485
,共5页
孔令娜%占书箱%黄成%马陶陶%林翔%李俊
孔令娜%佔書箱%黃成%馬陶陶%林翔%李俊
공령나%점서상%황성%마도도%림상%리준
栀子苷%HSC-T6%肝纤维化%Akt/mTOR/p70S6K
梔子苷%HSC-T6%肝纖維化%Akt/mTOR/p70S6K
치자감%HSC-T6%간섬유화%Akt/mTOR/p70S6K
geniposide%HSC-T6%liver fibrosis%Akt/mTOR/p70S6K
目的探讨栀子苷抑制血小板衍生生长因子(PDGF)介导的大鼠肝星状细胞(HSC-T6)增殖活化的作用及其可能机制。方法培养 HSC-T6,体外给予不同浓度(20、50、100、200、400μg/ml)的栀子苷,通过MTT法检测细胞的活力;选取20、50、100μg/ml的栀子苷, PDGF刺激后,采用MTT、实时定量PCR( qRT-PCR)和Western blot 法检测细胞增殖和细胞活化标志物α-平滑肌肌动蛋白(α-SMA)的表达;进一步采用Western blot 法检测栀子苷对MAPK通路蛋白 P-ERK、P-p38和 Akt/mTOR/p70S6K 通路蛋白的表<br> 达。结果栀子苷可以抑制PDGF诱导的HSC-T6的增殖和减少活化标志物α-SMA的表达,并且明显抑制 Akt、mTOR和p70S6K的磷酸化水平,但是对ERK、p38活化水平无显著影响。结论栀子苷可以抑制PDGF诱导的HSC-T6的增殖与活化,可能起到抗纤维化的作用,这一作用的产生可能与Akt/mTOR/p70S6K通路有关。
目的探討梔子苷抑製血小闆衍生生長因子(PDGF)介導的大鼠肝星狀細胞(HSC-T6)增殖活化的作用及其可能機製。方法培養 HSC-T6,體外給予不同濃度(20、50、100、200、400μg/ml)的梔子苷,通過MTT法檢測細胞的活力;選取20、50、100μg/ml的梔子苷, PDGF刺激後,採用MTT、實時定量PCR( qRT-PCR)和Western blot 法檢測細胞增殖和細胞活化標誌物α-平滑肌肌動蛋白(α-SMA)的錶達;進一步採用Western blot 法檢測梔子苷對MAPK通路蛋白 P-ERK、P-p38和 Akt/mTOR/p70S6K 通路蛋白的錶<br> 達。結果梔子苷可以抑製PDGF誘導的HSC-T6的增殖和減少活化標誌物α-SMA的錶達,併且明顯抑製 Akt、mTOR和p70S6K的燐痠化水平,但是對ERK、p38活化水平無顯著影響。結論梔子苷可以抑製PDGF誘導的HSC-T6的增殖與活化,可能起到抗纖維化的作用,這一作用的產生可能與Akt/mTOR/p70S6K通路有關。
목적탐토치자감억제혈소판연생생장인자(PDGF)개도적대서간성상세포(HSC-T6)증식활화적작용급기가능궤제。방법배양 HSC-T6,체외급여불동농도(20、50、100、200、400μg/ml)적치자감,통과MTT법검측세포적활력;선취20、50、100μg/ml적치자감, PDGF자격후,채용MTT、실시정량PCR( qRT-PCR)화Western blot 법검측세포증식화세포활화표지물α-평활기기동단백(α-SMA)적표체;진일보채용Western blot 법검측치자감대MAPK통로단백 P-ERK、P-p38화 Akt/mTOR/p70S6K 통로단백적표<br> 체。결과치자감가이억제PDGF유도적HSC-T6적증식화감소활화표지물α-SMA적표체,병차명현억제 Akt、mTOR화p70S6K적린산화수평,단시대ERK、p38활화수평무현저영향。결론치자감가이억제PDGF유도적HSC-T6적증식여활화,가능기도항섬유화적작용,저일작용적산생가능여Akt/mTOR/p70S6K통로유관。
Objective To investigate the effect of geniposide on regulating the proliferation and activation of PDGF-induced HSC-T6 cells. Methods HSC-T6 cells were cultivated by geniposide with different concentrations (0, 20, 50, 100, 200, 400 μg/ml), and or after the cells were stimulated with PDGF, respectively. Cell activity, mRNA and total protein expressions were assayed by MTT, qRT-PCR and Western blot. Results The geniposide pretreatment effectively inhibited PDGF-mediated proliferation and the expressions of the activation markers (α-SMA) in HSC-T6, and also inhibited the phosphorylation levels of Akt,mTOR and p70S6K. But the geniposide couldn′t affect the activation levels of ERK and p38. Furthermore,the protein of the MAPK pathway ( P-ERK and P-p38) and Akt/mTOR/p70S6K signaling pathway were detected by Western blot. Conclusion The proliferation and activation of HSC-T6 induced by PDGF are inhibited by geniposide treatment, and then it maybe provide new i-deas and targets for the prevention of liver fibrosis, which is probably through modulating the Akt/mTOR/p70S6K signaling pathway.